FDA's Off-Label Comms Guidance Is A Reluctant Step Forward

By Jeffrey Shapiro and Lisa Dwyer · November 6, 2023, 2:37 PM EST

Last month, the U.S. Food and Drug Administration published a draft guidance making recommendations for permissible proactive communications to health care providers regarding unapproved uses of approved or cleared medical products,...

To view the full article, register now.